SCHEMBL11323980

SCHEMBL11323980

[CH2]C(C)(O)OCCCCC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.39
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 2/20 0.36
LPAR3 Q9UBY5 6/20 0.35
LPAR2 Q9HBW0 5/20 0.35
LPAR1 Q92633 2/20 0.35
NAAA Q02083 1/20 0.35
CES2 O00748 2/20 0.35
GBA1 P04062 1/20 0.34
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27638107 0.98 CES1 (0.42) CES1CA12CA1CA2CA9
SCHEMBL9184838 0.93
SCHEMBL8414742 0.81 CES1 (0.44) CES1CA12CA1CA2CA9
SCHEMBL27436364 0.81 CES1 (0.44) CES1CA12CA1CA2CA9
SCHEMBL2808705 0.80 CES1 (0.42) CES1CA12CA1CA2CA9
SCHEMBL17048683 0.80 TSHR (0.35) CA12CA1CA2CA9MEN1
SCHEMBL2316053 0.80 TSHR (0.35) CA12CA1CA2CA9MEN1
SCHEMBL8769729 0.78 CES1 (0.45) CES1CA12CA1CA2CA9
SCHEMBL28813963 0.78 TSHR (0.40) CA12CA1CA2CA9MEN1
SCHEMBL15308094 0.78 CES1 (0.45) CES1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0005318-B1 N-HETEROCYCLYL-4-PIPERIDINAMINES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, INTERMEDIATES THEREFOR, AND METHOD FOR THE PREPARATION OF THE INTERMEDIATES JANSSEN PHARMACEUTICA N.V. (BE) 1982-01-06 EP disclosed
EP-0005318-A1 N-Heterocyclyl-4-piperidinamines, methods for their preparation, pharmaceutical compositions comprising them, intermediates therefor, and method for the preparation of the intermediates JANSSEN PHARMACEUTICA N.V. (BE) 1979-11-14 EP disclosed